News and Comments

Biotech Firms with Guaranteed Growth Potential

  Thursday, July 07, 2016

Good news is not always great news that makes a difference. In the drug industry, clinical trial results that demonstrate a drug has fulfilled the requirements of the trials, including the primary and secondary endpoints does not always guarantee that the drug will be successful if and when it hits the market. Experience and follow up on certain firms enables us to see the real light at the end of the tunnel, not just celebrate reaching the end of it without knowing what to expect outside. This makes a big difference.  More...

THERAVANCE: BECAME TEMPTING TO INVESTORS ANR TO ITS PARTNER

  Monday, January 07, 2013

Using scientific skills towards building pipelines of promising products does not guarantee a happy ending for a small biotech firm. Pipelines’ breakthroughs need managements’ capabilities and swiftness of actions, which would walk them through the safest and fastest road towards approvals.  We believe Theravance (THRX) has benefited from both its scientists and management. The firm has come nearer than ever to reaching a happy beginning of substantial growth, or perhaps, a happy ending through acquisition, probably, by its partner GlaxoSmithKline (GSK).  More...


Recent Postings


Archive


Tags

ABBVIE (ABBV) CompuGen (CGEN) Theravance Bio Pharma (TBPH) GUARDIAN HEALTH Genentech Alder Biopharmaceuticals (ALDR) Seattle Genetics (SGEN) Auspex (ASPX) INNOVIVA (INVA) Gilead (GILD) Human Longevity (HLI) VANDA (VNDA) Ridaforolimus KERYX (KERX) JUNO (JUNO) Spike Therapeutics (ONCE) RenenxBio (RGNX) Zerenex Advaxis (ADXS) IDERA (IDRA) PTC Therapeutics (PTCT) ImmunoGen (IMGN) Sanofi (SNA) Ziofpharm (ZIOP) Anadys (ANDS) Intrexon (XON) Sanofi (SNY) ACADIA (ACAD) Merck (MRK) Mirati Therapeutics (MRTX) Abbott Laboratories (ABT) OSI (OSIP) ARCA (ABIO) Vitae Pharmaceuticals (VTAE) Agenus (AGEN Endometrial Cancer Editas (EDIT) Roche (ROCHE) Tysabri GlaxoSmithKline (GSK) Velcade (bortezomib) Sanofi-Aventis (SAN) Pluristem (PSTI) TOKAI (TKAOI) Sarepta (SRPT) Sequenom (SQNM) Idenix (IDIX) CEMPRA (CEMP) Anacor (ANAC) NANTKWEST (NK) Roche (RHHBY) Regeneron (REGN) Theravance (THRX) Ocular Therapeutix (OCUL) Ionis (IONS) C4 Therapeutics HALOZYME (HALO) Exelixis (EXEL) Biocryst (BCRX) Inovio (INO) Micromet (MITI) MODERNA Adaptimmune (ADAP) Intermune (ITMN) Galena (GALE) Human Genome Sciences (HGSI) Trastuzumab-DM1 ADVENTRIX (ANX) Xoma (XOMA) Rapamune Intercept (ICPT) Illumina (ILMN) ZALTRAP™ Global Cell Therapeutics (GBT) Agenus (AGEN) Dendreon (DNDN) SERES THERAPEUTICS (MCRB) KITE (KITE) Alnylam (ALNY) Dynavax (DVAX) Array Pharmaceuticals (ARRY) Revlimid (lenolidamide) Biogen Idec (BIIB) AERIE PHARMACEUTICALS Sangamo (SGMO) Telaprevir Elan (ELN) Cytokinetics (CYTK) SYNTA (SNTA) Valeant Pharmaceuticals International (VRX) Herceptin NOVOCURE (NVCR) galapagos (GLPG) Incyte (INCY) Vertex (VRTX) Aimmune Therapeutics (AIMT) Bellicum (BLCM) REGULUS (RGLS) Prolor Biotech (PBTH) NEKTAR (NKTR)) AstraZeneca (AZN) AGOS (ARGS) CRISPR Therapeutics (CRSP) Onyx (ONXX) ISIS (ISIS) Benlysta (belimumab) SUNESIS PHARMACEUTICALS (SNSS) BIOMARIN (BMRN) Prosensa (RNA) Ariad (ARIA) Bristol-Myers Squibb (BMY) Jazz Pharmaceuticals (JAZZ) Amgen (AMGN) ARGOS (ARGS) Multiple Myeloma